Korea Investment Partners is a Seoul-based venture capital and private equity firm with more than three decades of investing experience. It operates globally from its Seoul headquarters with offices in Shanghai, Beijing and Sunnyvale, and manages multiple funds that invest across a broad spectrum of sectors including business-to-business services, media, healthcare, information technology, manufacturing, life sciences, oncology, mobile and gaming, augmented reality, industrials, real estate technology, mortgage technology, advertising technology, advanced manufacturing, the Internet of Things and mobility technologies. The firm has backed notable companies such as Kakao, Naver, YG Entertainment, Osstem Implant, Bodyfriend and Didi Chuxing, reflecting its emphasis on innovative entrepreneurs and large-scale opportunities.
Hisense Bio offers treatment for intractable dental diseases. They provide research on original technology for tooth development and dentin regeneration. They developed physiological dentin regeneration technology and periodontal ligament regeneration technology based on basic dental research . They offer treatment of intractable dental diseases such as tooth decay, dental hypersensitivity, tooth decay, dental caries, and periodontal disease.
eBrace
Series B in 2020
eBrace is a company focused on the research, development, and production of digital 3D printing technology specifically tailored for orthodontics. The firm specializes in creating innovative solutions for dental applications, including bracketless invisible appliances, customized lingual invisible appliances, and dentures. By leveraging advanced 3D printing techniques, eBrace aims to deliver precise and detailed dental products that meet the needs of both practitioners and patients.
Hisense Bio
Series B in 2019
Hisense Bio offers treatment for intractable dental diseases. They provide research on original technology for tooth development and dentin regeneration. They developed physiological dentin regeneration technology and periodontal ligament regeneration technology based on basic dental research . They offer treatment of intractable dental diseases such as tooth decay, dental hypersensitivity, tooth decay, dental caries, and periodontal disease.
Hisense Bio
Series A in 2018
Hisense Bio offers treatment for intractable dental diseases. They provide research on original technology for tooth development and dentin regeneration. They developed physiological dentin regeneration technology and periodontal ligament regeneration technology based on basic dental research . They offer treatment of intractable dental diseases such as tooth decay, dental hypersensitivity, tooth decay, dental caries, and periodontal disease.
Gloud
Gloud offers dental digital and digital practice transformation services.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.